LXJ-02
LXJ-02 is a potent inhibitor of EDPs/EBP peptide–protein interaction, with the KD of 117 μM for EDPs. LXJ-02 activates the macrophage-MMP-12 axis to increase MMP-12 expression and degrade ECM components like elastin.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2672508-37-9
- Formule: C94H159N19O34
- Masse moléculaire:2099.37
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
CAS No. 2672508-37-9
-
Masse moléculaire 2099.37
-
Formule C94H159N19O34
-
Sequence
{PEG2-PEG2}-{gamma-Glu}-{CO(CH2)18CO2H)}-Val-{Iva}-Gly-Ser-Pro-Ser-Ala-Gln-Glu-Glu-Ala-Ser-Pro-Ala-NH2
-
Sequence Shortening
{PEG2-PEG2}-{gamma-Glu}-{CO(CH2)18CO2H)}-V-{Iva}-GSPSAQEEASPA-NH2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)